Early palliative care lowers hospital costs in patients with advanced cancer
the ONA take:
Earlier palliative care consultation during hospital admission is associated with lower cost of hospital stay for patients admitted with a diagnosis of advanced cancer, a study published in the Journal of Clinical Oncology has shown.
For the prospective study, researchers collected clinical and cost data for adult patients admitted to five hospital in the United States from 2007 to 2011. The researchers identified 969 patients. Of those, 256 received a palliative care consultation and 713 received usual care only.
Results showed that a palliative care consultation within 6 days of admission is estimated to lower costs by $1,312 compared with no intervention. Researchers found that a palliative care consultation within 2 days reduced costs by $2,280. These figures correspond to a 14% and 24% decrease, respectively, in cost of hospital stay.
The findings suggest that early palliative care should be more widely adopted.
Earlier palliative care consultation during hospital admission is associated with lower cost of hospital stay.
- Blood Test Predicts Stem Cell Transplant Success in Myelodysplastic Syndrome
- Immunotherapy and the Future of Prostate Cancer Treatment
- Trends in Behaviors, Medical Practice Indicate Mortality From Melanoma Will Decline
- Pembrolizumab Active Against Rare Melanoma, Extends Survival in Bladder Cancer
- Elderly with NSCLC Can Tolerate Aggressive Radiation Therapy Treatments
- Survivors Reporting Chronic Neuropathic Pain Struggle to Retain Jobs
- Timing of Chemotherapy Infusion Affects Inflammatory Response to Chemotherapy
- Postoperative Gemcitabine Plus Capecitabine: A New Standard of Care for Pancreatic Cancer
- Blood-Forming Stem Cell Transplants (Fact Sheet)
- Nut Consumption Inversely Associated With Lung Cancer Risk
- E-cigarettes and Replacement Nicotine Therapy Safer Than Tobacco Use
- National Health Care Spending Expected to Grow Five Percent Annually
- Patients With Urologic Cancer Need Psycho-oncologic Support to Manage High Stress
- 1 Year of Adjuvant Trastuzumab Improves Long-Term DFS in Early Breast Cancer
- Lenalidomide Maintenance Appears Efficacious for Relapsed DLBCL
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|